-
-
-
-
-
-
-
KemPharm (KMPH) Announces Board and Leadership Changes
-
-
-
-
-
-
-
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
-
-
-
-
-
-
-
KemPharm Issues Letter to Shareholders
-
-
-
-
-
-
-
KemPharm Issues Letter to Shareholders
-
-
-
-
-
-
-
After-Hours Movers 10/30: (CAI) (EXAS) (ARNC) Higher; (CLVS) (DDD) (FB) Lower (more...)
-
-
-
-
923,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All